100
Participants
Start Date
October 31, 2023
Primary Completion Date
December 31, 2024
Study Completion Date
December 31, 2024
Research questions
"Stage 1: Secondary analysis of a previous international survey to identify items~Stage 2: Cognitive debriefing interviews with about 10 people living with iMCD to assess the content validity of the items~Stage 3: Completion of questionnaire to finalise scale~Stage 4a: Re-administering of follow-up questionnaire to Stage 3 patients to assess minimally important clinical difference. Test-retest will be calculated only in patients exhibiting no change.~Stage 4b: Qualitative interviews with a subset of participants from Stages and 4 to help with interpretation of meaningful difference from their perspective"
Collaborators (1)
University of Sheffield (ScHARR)
UNKNOWN
KMC Health Care
UNKNOWN
Castleman Disease Collaborative Network (CDCN)
UNKNOWN
RECORDATI GROUP
INDUSTRY